Cytek Biosciences, Inc. · NASDAQ:CTKB
Boston Partners reported a 5.91% stake in Cytek Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 4, 2026
Boston Partners reported a 5.91% stake in Cytek Biosciences, Inc., 7,635,145 shares, as a passive investor on Jun 30, 2026. Filed Aug 4, 2026 (Schedule 13G).
- Stake
- 5.91%
- Shares
- 7,635,145
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Boston Partners | 5.91% | 7,635,145 |